• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量评估干预措施的跨部门和“同一个健康”影响:抗菌药物耐药性的范围审查和案例研究

Quantitatively evaluating the cross-sectoral and One Health impact of interventions: A scoping review and case study of antimicrobial resistance.

作者信息

Naylor Nichola R, Lines Jo, Waage Jeff, Wieland Barbara, Knight Gwenan M

机构信息

London School of Hygiene & Tropical Medicine, London, United Kingdom.

International Livestock Research Institute (ILRI), Addis Ababa, Ethiopia.

出版信息

One Health. 2020 Nov 14;11:100194. doi: 10.1016/j.onehlt.2020.100194. eCollection 2021 Jun.

DOI:10.1016/j.onehlt.2020.100194
PMID:33304982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7718152/
Abstract

BACKGROUND

Current frameworks evaluating One Health (OH) interventions focus on intervention-design and -implementation. Cross-sectoral impact evaluations are needed to more effectively tackle OH-issues, such as antimicrobial resistance (AMR). We aimed to describe quantitative evaluation methods for interventions related to OH and cross-sectoral issues, to propose an explicit approach for evaluating such interventions, and to apply this approach to AMR.

METHODS

A scoping review was performed using WebofScience, EconLit, PubMed and gray literature. Quantitative evaluations of interventions that had an impact across two or more of the human, animal and environment sectors were included. Information on the interventions, methods and outcome measures found was narratively summarised. The information from this review informed the construction of a new approach to OH-related intervention evaluation, which then was applied to the field of AMR.

RESULTS

The review included 90 studies: 73 individual evaluations (from 72 papers) and 18 reviews, with a range of statistical modelling ( = 13 studies), mathematical modelling ( = 53) and index-creation/preference-ranking ( = 14) methods discussed. The literature highlighted the need to (I) establish stakeholder objectives, (II) establish quantifiable outcomes that feed into those objectives, (III) establish agents and compartments that affect these outcomes and (IV) select appropriate methods (described in this review) accordingly. Based on this, an evaluation model for AMR was conceptualised; a decision-tree of intervention options, a compartmental-microeconomic model across sectors and a general-equilibrium (macroeconomic) model are linked. The outcomes of this multi-level model (including cost-utility and Gross Domestic Product impact) can then feed into multi-criteria-decision analyses that weigh respective impact estimates alongside other chosen outcome estimates (for example equity or uncertainty).

CONCLUSION

In conclusion, stakeholder objectives are key in establishing which evaluation methods (and associated outcome measures) should be used for OH-related interventions. The stated multi-level approach also allows for sub-systems to be modelled in succession, where resources are constrained.

摘要

背景

当前评估“同一健康”(OH)干预措施的框架侧重于干预设计和实施。需要进行跨部门影响评估,以更有效地解决OH问题,如抗菌药物耐药性(AMR)。我们旨在描述与OH及跨部门问题相关干预措施的定量评估方法,提出评估此类干预措施的明确方法,并将该方法应用于AMR。

方法

使用Web of Science、EconLit、PubMed和灰色文献进行范围综述。纳入对人类、动物和环境两个或更多部门产生影响的干预措施的定量评估。对所发现的干预措施、方法和结果指标信息进行叙述性总结。本次综述的信息为构建一种新的OH相关干预评估方法提供了依据,该方法随后应用于AMR领域。

结果

该综述纳入90项研究:73项个体评估(来自72篇论文)和18篇综述,讨论了一系列统计建模(n = 13项研究)、数学建模(n = 53)和指标创建/偏好排序(n = 14)方法。文献强调需要(I)确定利益相关者目标,(II)确定有助于实现这些目标的可量化结果,(III)确定影响这些结果的因素和部分,以及(IV)相应地选择适当方法(本综述中描述)。基于此,构建了AMR评估模型;干预选项决策树、跨部门的部分微观经济模型和一般均衡(宏观经济)模型相互关联。然后,这个多层次模型的结果(包括成本效益和国内生产总值影响)可用于多标准决策分析,将各自的影响估计与其他选定的结果估计(如公平性或不确定性)进行权衡。

结论

总之,利益相关者目标是确定应使用哪些评估方法(及相关结果指标)来评估OH相关干预措施的关键。所述的多层次方法还允许在资源受限的情况下依次对子系统进行建模。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca8/7718152/f761e71698ba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca8/7718152/e5bf39a5b6f7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca8/7718152/f761e71698ba/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca8/7718152/e5bf39a5b6f7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca8/7718152/f761e71698ba/gr2.jpg

相似文献

1
Quantitatively evaluating the cross-sectoral and One Health impact of interventions: A scoping review and case study of antimicrobial resistance.定量评估干预措施的跨部门和“同一个健康”影响:抗菌药物耐药性的范围审查和案例研究
One Health. 2020 Nov 14;11:100194. doi: 10.1016/j.onehlt.2020.100194. eCollection 2021 Jun.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Economic Evaluation of Interventions to Reduce Antimicrobial Resistance: A Systematic Literature Review of Methods.减少抗菌药物耐药性干预措施的经济学评估:方法的系统文献综述
Pharmacoeconomics. 2025 Jun;43(6):631-646. doi: 10.1007/s40273-024-01468-7. Epub 2025 Mar 6.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
What is the volume, quality and characteristics of evidence relating to the effectiveness and cost-effectiveness of multi-disciplinary occupational health interventions aiming to improve work-related outcomes for employed adults? An evidence and gap map of systematic reviews.旨在改善成年就业者与工作相关结果的多学科职业健康干预措施的有效性和成本效益相关证据的数量、质量及特征是什么?一项系统评价的证据与差距图谱。
Campbell Syst Rev. 2024 May 14;20(2):e1412. doi: 10.1002/cl2.1412. eCollection 2024 Jun.
6
Evaluating Integrated Surveillance for Antimicrobial Use and Resistance in England: A Qualitative Study.评估英格兰抗菌药物使用与耐药性综合监测:一项定性研究。
Front Vet Sci. 2021 Nov 2;8:743857. doi: 10.3389/fvets.2021.743857. eCollection 2021.
7
One Health Lens for Antimicrobial Resistance Research and Funding: A Systematic Review.抗菌药物耐药性研究与资金的“同一健康”视角:一项系统综述
OMICS. 2023 Dec;27(12):570-580. doi: 10.1089/omi.2023.0049. Epub 2023 Oct 18.
8
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.行为修正干预对初级保健中无法用医学解释的症状:系统评价和经济评估。
Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460.
9
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
10
Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.将公平性问题纳入成本效益分析中:系统文献回顾。
Pharmacoeconomics. 2022 Jan;40(1):45-64. doi: 10.1007/s40273-021-01094-7. Epub 2021 Oct 29.

引用本文的文献

1
Systematic review on evaluation tools applicable to One Health surveillance systems: A call for adapted methodology.适用于“同一健康”监测系统的评估工具的系统评价:呼吁采用适应性方法。
One Health. 2025 Feb 14;20:100995. doi: 10.1016/j.onehlt.2025.100995. eCollection 2025 Jun.
2
Awareness and capacities of 103 countries to address antimicrobial resistance from 2017 to 2020.2017年至2020年103个国家应对抗菌药物耐药性的意识和能力。
Sci Rep. 2024 Dec 4;14(1):30184. doi: 10.1038/s41598-024-80984-0.
3
An agent-based model for collaborative learning to combat antimicrobial resistance: proof of concept based on broiler production in Senegal.

本文引用的文献

1
Selection and co-selection of antibiotic resistances among Escherichia coli by antibiotic use in primary care: An ecological analysis.初级保健中抗生素使用对大肠杆菌抗生素耐药性的选择和共同选择:生态分析。
PLoS One. 2019 Jun 10;14(6):e0218134. doi: 10.1371/journal.pone.0218134. eCollection 2019.
2
The challenge of antimicrobial resistance: What economics can contribute.抗微生物药物耐药性的挑战:经济学可以做出哪些贡献。
Science. 2019 Apr 5;364(6435). doi: 10.1126/science.aau4679.
3
Economic Evaluation of Environmental Interventions: Reflections on Methodological Challenges and Developments.
一种基于主体模型的协作学习以对抗抗菌素耐药性:基于塞内加尔肉鸡生产的概念验证
Sci One Health. 2023 Nov 4;2:100051. doi: 10.1016/j.soh.2023.100051. eCollection 2023.
4
Current evidence of the economic value of One Health initiatives: A systematic literature review.“同一健康”倡议经济价值的当前证据:一项系统的文献综述。
One Health. 2024 May 9;18:100755. doi: 10.1016/j.onehlt.2024.100755. eCollection 2024 Jun.
5
Navigating One Health in research-for-development: Reflections on the design and implementation of the CGIAR Initiative on One Health.在发展研究中践行“同一个健康”理念:关于国际农业研究磋商组织“同一个健康”倡议的设计与实施的思考
One Health. 2024 Mar 13;18:100710. doi: 10.1016/j.onehlt.2024.100710. eCollection 2024 Jun.
6
AHHME: A model for estimating the holistic cost-effectiveness of antimicrobial resistance interventions in food animal production.AHHME:一种用于评估食用动物生产中抗菌药物耐药性干预措施整体成本效益的模型。
One Health. 2023 Sep 16;17:100629. doi: 10.1016/j.onehlt.2023.100629. eCollection 2023 Dec.
7
The WHO costing and budgeting tool for national action plans on antimicrobial resistance-a practical addition to the WHOle toolkit.世界卫生组织抗微生物药物耐药性国家行动计划成本核算与预算编制工具——世界卫生组织整个工具包的实用补充。
JAC Antimicrob Resist. 2023 May 25;5(3):dlad064. doi: 10.1093/jacamr/dlad064. eCollection 2023 Jun.
8
Antimicrobial Resistance in the Global Health Network: Known Unknowns and Challenges for Efficient Responses in the 21st Century.全球卫生网络中的抗菌素耐药性:21世纪已知的未知因素及有效应对挑战
Microorganisms. 2023 Apr 17;11(4):1050. doi: 10.3390/microorganisms11041050.
9
Establishment of an indicator framework for global One Health Intrinsic Drivers index based on the grounded theory and fuzzy analytical hierarchy-entropy weight method.基于扎根理论和模糊层次分析法-熵权法的全球同一健康内在驱动因素指标框架的建立。
Infect Dis Poverty. 2022 Dec 8;11(1):121. doi: 10.1186/s40249-022-01042-3.
10
Changing food systems and infectious disease risks in low-income and middle-income countries.改变低收入和中等收入国家的食物系统与传染病风险。
Lancet Planet Health. 2022 Sep;6(9):e760-e768. doi: 10.1016/S2542-5196(22)00116-4.
环境干预措施的经济评价:对方法学挑战与发展的反思。
Int J Environ Res Public Health. 2018 Nov 5;15(11):2459. doi: 10.3390/ijerph15112459.
4
A One Health Evaluation of the University of Copenhagen Research Centre for Control of Antibiotic Resistance.哥本哈根大学抗生素耐药性控制研究中心的“同一健康”评估。
Front Vet Sci. 2018 Aug 21;5:194. doi: 10.3389/fvets.2018.00194. eCollection 2018.
5
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.PRISMA 扩展用于范围审查 (PRISMA-ScR): 清单和解释。
Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4.
6
Application of the NEOH Framework for Self-Evaluation of One Health Elements of a Case-Study on Obesity in European Dogs and Dog-Owners.NEOH框架在欧洲犬类和犬主肥胖案例研究的“同一健康”要素自我评估中的应用。
Front Vet Sci. 2018 Jul 20;5:163. doi: 10.3389/fvets.2018.00163. eCollection 2018.
7
Brucellosis Control in Malta and Serbia: A One Health Evaluation.马耳他和塞尔维亚的布鲁氏菌病防控:“同一健康”评估
Front Vet Sci. 2018 Jul 3;5:147. doi: 10.3389/fvets.2018.00147. eCollection 2018.
8
A case-study based framework for assessing the multi-sector performance of green infrastructure.基于案例研究的绿色基础设施多部门绩效评估框架。
J Environ Manage. 2018 Oct 1;223:371-384. doi: 10.1016/j.jenvman.2018.06.029. Epub 2018 Jun 21.
9
Estimating the burden of antimicrobial resistance: a systematic literature review.评估抗菌药物耐药负担:系统文献综述。
Antimicrob Resist Infect Control. 2018 Apr 25;7:58. doi: 10.1186/s13756-018-0336-y. eCollection 2018.
10
Are Food Animals Responsible for Transfer of Antimicrobial-Resistant Escherichia coli or Their Resistance Determinants to Human Populations? A Systematic Review.食用动物会将耐抗生素大肠杆菌或其耐药决定因子传播给人类吗?一项系统综述。
Foodborne Pathog Dis. 2018 Aug;15(8):467-474. doi: 10.1089/fpd.2017.2411. Epub 2018 Apr 30.